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Abstract
Objective: Reports on leptin concentrations in pediatric populations lack reference values for infants in the first months of
life. Our study was conducted on healthy full-term infants between 2002 and 2012 to determine serum leptin reference
values in subjects less than 18 months old.
Methods: Routine outpatient blood tests for serum leptin were performed on 317 infants using a radioimmunoassay
method. The median and 10th–90th percentiles were calculated to obtain reference values using quantile regression. Values
established in this study were compared with another independent cohort of 110 infants.
Results: The median (IQR) serum leptin concentration in the infants was 2.37 (3.26) ng/ml (n= 317). The median leptin
concentration was 2.81 (3.49) ng/ml (n= 202) in infants younger than 6 months of age, 1.44 (2.27) ng/ml (n= 59) in infants
between 6–12 months of age and 1.77 (2.05) ng/ml (n= 56) in infants between 12–18 months of age. We obtained leptin
reference values based on age by estimating the lower and upper percentiles. In the entire cohort, the median (IQR) leptin
concentration was 2.22 (3.11) ng/ml in males (n= 168) and 2.60 (3.32) ng/ml in females (n= 149). According to the type of
feeding median serum leptin concentration was higher in breast-fed infants (n = 188) than in formula-fed infants (n = 129)
(2.63 (3.34) ng/ml vs. 2.12 (2.77) ng/ml; p,0.05).
Conclusions: Our data revealed no gender difference in leptin concentration in early infancy. After 6 months of life, leptin
concentrations decreased slightly. We used a large cohort to confirm that breast-fed infants had significantly higher serum
leptin levels than formula-fed infants during the first 6 months of life, although this difference disappeared later in life. In
this study, we defined the leptin reference range in healthy infants in the first 18 months of life according to the Clinical and
Laboratory Standards Institute (CLSI).
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Introduction
Leptin, a 167-amino-acid hormone that belongs to the
adipocytokine family, was discovered in 1994. Leptin is encoded
by the obesity (ob) gene on human chromosome 7q31.3 [1]. An
autosomal recessive mutation in ob results in profound hyperpha-
gia, obesity, reduced energy expenditure, hyperinsulinemia and
insulin resistance [2]. Leptin is predominantly produced by white
adipose tissue in an amount proportional to the body fat mass and,
to a lesser extent, by the gastrointestinal tract, skeletal muscle,
human placenta, mammary gland and foetal tissues [3,4]. The
main function of leptin is to inform the hypothalamic structures
regarding energy deposits and to help regulate energy balance;
leptin exerts an anorexigenic effect and increases energy expen-
diture [5]. However, during early infancy, leptin does not appear
to play an anorexigenic role; leptin maintains an increased
appetite in infants to promote their survival during the period in
which they lack feeding independence [6].
Leptin also exert various peripheral functions, with pleiotropic
effects on the physiology and pathophysiology of energy homeo-
stasis, endocrinology and metabolism [7]. Evidence shows that
serum leptin concentrations reflect body fat mass during foetal life,
infancy, childhood and adulthood [8,9]. Leptin has been detected
in the foetus during the second trimester of pregnancy, and the
levels of this hormone gradually increase with the development of
foetal adipose tissue [10]. During periods of energy balance
(weight maintenance), leptin concentrations in the blood reflect
total body fat in both humans and mice. However, during periods
of energy imbalance (gain or loss of weight), leptin concentrations
indicate the direction of the imbalance. Therefore, leptin acts not
only as an ‘‘adipostat’’ by signalling information about the amount
of body fat to the brain but also as a sensor of energy imbalance
[11].
It is conceivable that serum leptin concentrations in breastfed
(BF) infants are related to adipose tissue production during the first
months of life and to the leptin content of human milk. Leptin
concentrations in breast milk positively correlate with maternal
circulating leptin levels, BMI, and adiposity [12]. Data in the
literature have described the changes that occur in leptin levels
during intrauterine life, childhood and adulthood. However, large
gaps remain in our knowledge of normal leptin levels during
various periods of life, and a complete database of reference values
is not yet available.
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Reference intervals are essential for the interpretation of clinical
laboratory tests and for the care of patients with signs or a family
history of endocrine disorders or metabolic diseases. The aim of
the present study was to establish and validate reference ranges of
serum leptin concentrations in healthy Caucasian infants aged up
to 18 months for use in clinical practice.
Methods
Reference Cohort
We enrolled AGA healthy term infants who were admitted to
the Department of Paediatrics of the University of Turin, Regina
Margherita Children’s Hospital, between 2002 and 2012. The
infants underwent blood tests during routine outpatient examina-
tions. The inclusion criteria were the following: age ,18 months;
gestational age between 37 and 42 weeks; birth weight between
2500 and 4000 g; Apgar score .7 at 5 minutes; and exclusively
BF or exclusively FF for at least 6 months. Following the initial 6-
month period, all of the infants were fed based on the same
complementary food scheme. The exclusion criteria included
neonatal disease, fever, chronic illness or pathology indicating
compromised growth.
At enrolment, the infants were weighed naked prior to feeding
(electronic integrating scale, SECA, model 757, Vogel & Halke,
Hamburg, Germany), the crown-to-heel length was measured
(Harpenden Stadiometer, Holtain, Ltd, Crosswell, Crymych,
Pembs., UK), the BMI was calculated (ratio of body weight (kg)
to the square of length (m2)), and serum leptin levels were
measured. The baseline characteristics of the infants at recruit-
ment are summarized in Table 1.
The study protocol was approved by the local Ethical
Committee at Ospedale Mauriziano - Ospedale Infantile Regina
Margherita - S. Anna Torino, and the infants’ parents provided
written consent to participate in the study.
Validation Cohort
Between January 2013 and June 2014, healthy term infants
visiting the Department of Paediatrics were screened for enrol-
ment in the study. The exclusion criteria for these patients were
identical to those used in the original study. The parents of 146
children who were eligible for the study were invited to participate
in the study. After providing informed consent, the parents were
asked to fill out screening questionnaires on health, learning and
behaviour. Thirty-six of the invited children did not participate in
this part of the study. A cohort of 110 infants (78 aged ,6 months,
17 aged 6–12 months, 15 aged 12–18 months) was used for
validation purposes.
Sample collection and analysis
Venous blood samples were collected from the infants at 8 a.m.,
which coincided with the routine clinical blood sampling to
minimise the disturbance to the infants. The samples were
collected following a 3-hour fasting period. To determine the
leptin concentration, serum was separated by centrifugation at
4000 rpm for 10 minutes and stored at 220uC. Immunoreactive
leptin was measured using a commercially available radioimmu-
noassay (RIA) kit (LEP R-40, Human-Leptin-RIA-Sensitive,
Mediagnost, Reutlingen, Germany) with a sensitivity of 0.04 ng/
ml (0.01 ng/ml with the procedure for increased sensitivity). The
intra-assay variation was less than 5%, and the inter-assay
variation did not exceed 7.6% One blood sample was taken from
each infant (n = 317). Each sample was divided into two serum
samples containing different concentrations of leptin; leptin
concentrations were measured 10 times in eight separate assays,
and the final value was the median value of the 10 measurements.
Statistical analysis
All the statistical analyses were conducted using SPSS software
(version 19.0, SPSS, Inc., Chicago, IL). The normality of the
distribution of the data was assessed with the Kolmogorov–
Smirnov test. Continuous variables were expressed as the means6
standard deviations or medians and interquartile ranges (25th and
75th percentiles). The median and the 10th and 90th percentiles
were calculated to obtain reference values using quantile
regression. Independent sample t-tests were used to compare the
characteristics of the patients in the reference and validation
cohorts for continuous data. Data that were not normally
distributed (serum leptin levels in different groups) were analysed
with the Mann–Whitney U test. Correlations are expressed by the
Spearman correlation coefficient.
Statistical significance was set at p,0.05.
Missing Data
No data were missing in either the reference cohort or the
validation cohort.
Results and Discussion
The median (IQR) serum leptin concentration in infants
(n=317) was 2.37 (3.26) ng/ml. Serum leptin values categorised
by the infants’ age, gender and type of feeding (breast vs. formula)
are shown in Table 2.
Hormone Concentration versus Age
We divided the reference cohort into 3 age groups at enrolment
and found that the median (IQR) leptin concentrations were 2.81
(3.49) ng/ml in group 1 (,6 months; n=202), 1.44 (2.27) ng/ml
in group 2 (6–12 months; n=59) and 1.77 (2.05) ng/ml in group 3
(12–18 months; n=56). The serum leptin levels were significantly
different between groups 1 and 2 (p,0.05) and between groups 1
and 3 (p,0.05).
Table 1. Baseline characteristics of infants in the reference cohort during recruitment.
Characteristics Mean Standard Deviation
Infant age (days) 185.09 160.36
Weight (kg) 6459.39 2127.02
Length (cm) 63.34 8.78
BMI (kg/m2) 15.71 2.18
Head Circumference (cm) 41.14 3.81
doi:10.1371/journal.pone.0113024.t001
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External Validation
To externally validate our results, the characteristics and serum
leptin levels of the patients in the reference cohort were compared
with those of the patients in the validation cohort; no significant
differences were found (Table 3).
Serum Leptin Reference Values
We categorized leptin reference values by patient age by
calculating the levels of the patients found in the lower and upper
percentiles (Figure 1).
Hormone Concentration versus Gender
We stratified the patients in the reference cohort by gender and
found that the median (IQR) leptin concentration was 2.22 (3.11)
ng/ml for males (n=168) and 2.6 (3.32) ng/ml for females
(n=149); the difference between the two groups was not
statistically significant. No significant differences in leptin concen-
trations were found among the three different age groups (,6
months, 6–12 months and 12–18 months) (Table 2).
Table 2. Serum leptin values according to infant’s age, gender and type of feeding.
Groups Serum leptin value (ng/ml) p- valuea
Gender
Subjects aged ,6 months
Males n= 111 2.56 (3.2) 0.28
Females n= 91 3.36 (3.86)
Subjects aged 6–12 months
Males n= 29 1.37 (2.26) 0.36
Females n= 30 1.66 (2.54)
Subjects aged 12–18 months
Males n= 28 1.42 (2.15) 0.16
Females n= 28 2.2 (1.22)
Type of feeding
Subjects aged ,6 months
Breastfed n=121 3.37 (3.56) 0.031
Formula fed n=81 2.2 (3.75)
Subjects aged 6–12 months
Breastfed n=29 2.28 (1.41) 0.65
Formula fed n=27 1.77 (1.98)
Subjects aged 12–18 months
Breastfed n=38 1.3 (2.5) 0.35
Formula fed n=21 1.8 (1.98)
aNormally distributed continuous variables were compared with independent sample t-tests. Variables that were not parametrically distributed were analysed with
Mann–Whitney U tests.
doi:10.1371/journal.pone.0113024.t002
Table 3. Characteristics of the patients in the reference cohort and validation cohort.
Characteristics
Reference Cohort
n =317
Validation
Cohort n =110 p- valued Reference versus Validation cohort
Infant age (days) a 185.09 (160.36) 159.40 (116.18) 0.123
Male Gender b 168 (53%) 50 (45%) 0.248
BMI (kg/m2) a 15.71 (2.18) 16.02 (1.98) 0,19
Serum leptin value (total sample) c 2.37 (3.26) 2.78 (3.45) 0.213
Serum leptin value (infants ,6 months) c 2.81 (3.49) 3.11 (2.79) 0.27
Serum leptin value (infants 6–12 months) c 1.44 (2.27) 1.8 (1.86) 0.16
Serum leptin value (infants 12–18 months) c 1.77 (2.05) 2.2 (1.5) 0.39
aMean (standard deviation).
bNumber of subjects (%).
cMedian (IQR).
dNormally distributed continuous variables were compared with independent sample t-tests. Variables that were not parametrically distributed were analyzed with
Mann–Whitney U tests.
doi:10.1371/journal.pone.0113024.t003
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Hormone Concentration versus Type of Feeding
Our cohort was divided according to the type of feeding the
infants received prior to weaning: the median (IQR) serum leptin
concentration was 2.63 (3.34) ng/ml in BF infants (n=188) and
2.12 (2.77) ng/ml in FF infants (n=129); the difference between
the BF and FF groups was statistically significant (p,0.05). The
median (IQR) leptin concentrations in infants younger than 6
months of age who were not yet weaned (n=202) were 3.37 (3.56)
ng/ml (exclusively BF infants (n=121)) and 2.2 (3.75) ng/ml
(exclusively FF infants (n=81)); the difference between the two
groups was statistically significant (p,0.05) (Figure 2). However,
no significant differences in leptin levels were found between the
BF and FF infants older than 6 months of age (after weaning)
(n=115) (Table 2).
Hormone Concentration versus BMI
Serum leptin concentrations were not correlated with the BMI
of the infant in either the entire sample or in the three different age
groups (p.0.05).
Discussion
In this study, we investigated serum leptin concentrations in a
group of healthy infants younger than 18 months of age. We
observed that leptin levels decrease when infants begin eating solid
foods at 6 months of age. According to our previous studies, BF
infants have significantly higher serum leptin levels than FF infants
during the first 6 months of life [13,14]; however, this difference
disappears later in life. The reason for this difference is not
completely understood. We propose that the leptin found in BF
infants includes leptin produced by the adipocytes of the infant
and leptin found in human milk. Leptin was detected in human
breast milk in 1997 [15], and recent studies have suggested that
leptin is destroyed by the pasteurization process used to produce
formula [16].
In experimental studies on neonatal rats, Casabiell et al
demonstrated that leptin is transferred from the maternal
circulation to BM; the leptin present in maternal milk that is
ingested during the suckling period can be absorbed by the
immature gastric mucosa of the pup and transferred to its
circulation [15]. Additionally, leptin receptors have been detected
in gastric epithelial cells and in the absorptive cells of the small
intestine in mice and humans, which suggests that leptin can pass
from milk to infant blood [17]. However, further studies are
needed to determine whether leptin present in human milk can
exert a biological effect on infants.
Figure 1. Reference serum leptin concentrations in healthy infants: median and 10th–90th centile (Error Bars 10%). (Source: self-
elaborated).
doi:10.1371/journal.pone.0113024.g001
Figure 2. Comparison of serum leptin values in breastfed and
formula-fed infants younger than 6 months of age (n=202).
The median (IQR) leptin concentration was 3.37 (3.56) ng/ml in the
exclusively BF infants (n= 121) and 2.2 (3.75) ng/ml in the exclusively FF
infants (n= 81); the difference between the two groups was statistically
significant (* p,0.05). (Source: self-elaborated).
doi:10.1371/journal.pone.0113024.g002
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Pico et al demonstrated that orally administered leptin is
absorbed by the immature gastric epithelium of the neonate and
exerts clear biological effects during the early stages of neonatal
life, including the down-regulation of endogenous leptin produc-
tion and the potential control of food intake during this period
[18].
Leptin has been proposed to be responsible for some of the
beneficial effects of breastfeeding and is thought to be involved in
preventing infants to obesity [19]. According to the nutritional
programming theory, nutrition during the early period of life is
related to the development of childhood obesity, adult obesity and
associated pathological conditions. It is well established that
genetic, hormonal and perinatal environmental factors acting
during the critical period of growth can lead to alterations in the
development of organs and systems; in particular, infants who
experience alterations in leptin profiles during early life are more
likely to develop metabolic disorders later in life. For this reason,
this adipocytokine can be considered a potential programming
factor [20,21].
Palou et al. found that supplementing rat pups with oral leptin
during the suckling period resulted in a decrease in food intake, a
preference for carbohydrates over fat, a reduced likelihood of
being overweight in adulthood and improvements in related
parameters such as leptin and insulin sensitivity [22]. Therefore,
the length of time during which an infant is breast-fed (up to 9
months of age) is inversely related to the infant’s risk of being
overweight in a dose-dependent manner [23]. In a recent follow-
up study, 8-year-old children who were BF as infants had
significantly lower weights, BMIs and heights than infants who
were FF. In this study, infants with lower serum leptin levels at
enrolment had a significantly higher BMI later in life [24].
Our data showed that there were no significant differences in
leptin concentrations between males and females in early infancy;
however, females tended to have higher serum leptin level than
males. These results are in agreement with those of previous
studies. Karakosta et al calculated gender-specific reference
intervals for leptin levels in cord blood in 398 healthy neonates
in Crete and found that females had higher levels of this hormone
than males [25]. Leptin levels have been shown to be consistently
higher in females than in males later in life [26,27]. We
hypothesize that these differences are related to differences in
body composition or hormone levels in males and females.
No significant correlation was found between serum leptin
concentrations and the BMI of the infant [8]. This phenomenon
could be specific to this period of life, as infants can experience an
energy imbalance that is correlated with leptin levels [11].
Leptin reference ranges have been shown to vary significantly,
as many parameters such as age, BMI, percent body fat, Tanner
pubertal stage, sex, ethnicity, circadian rhythm and assay method
can influence the levels of these hormones [28,29].
To the best of our knowledge, this is the first study to report
reference leptin values for a large sample of healthy infants
younger than 18 months of age. The advantages of this study
included a large sample size and the use of Clinical and
Laboratory Standards Institute (CLSI) criteria. Moreover, highly
selective criteria (e.g., a limited age range and the exclusion of
subjects who were fed both breast milk and formula) were used to
enroll participants, and samples were collected under similar
laboratory conditions (i.e., in the morning after a three-hour
fasting period). RIA methodology, which is used in the majority of
published studies on leptin, was used to compare groups in our
study.
Conclusions
A specific reference range of leptin levels can be used clinically
to interpret leptin values in healthy infants and in infants with
pathological conditions associated with an altered energy balance.
This study presents a range of serum leptin values in healthy
infants during the first 18 months of life. We found no differences
in leptin levels between males and females during early infancy;
however, leptin levels were slightly lower in males greater than 6
months of age. We confirmed that breast-fed infants had
significantly higher serum leptin levels than formula-fed infants
during the first 6 months of life; later in life, these differences
disappeared.
We created and validated a clinically useful tool for identifying
infants with higher serum leptin levels.
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